@NourAlmozain@AABB@NHSBT Yes- centralized data bases can be a big advantage for access of data. We have sickle cell disease patients in US that go to several different hospitals and it is always an adventure when they return with the development of new antibodies. #AABBpeptalk
@NourAlmozain@AABB How readily do find the facility releases the information. In the US there is sometimes hesistancy do to patient privacy concerns. #AABBpeptalk
@AABB At our pediatric hospital the red blood cells and plasma dosages are lowered and we aliquot an apheresis platelet depending upon three weight categories. What do you do? #AABBpeptalk
@MSromoski@AABB It has substantially increased compliance at one facility. The only issue is that when paper or downtime forms are needed, there is less proficiency for scanning and the documents sometimes are lost.#AABBpeptalk
@NourAlmozain@HermelinMD@AABB@SSMHealthSTL @impactlifeblood @GlennonTrauma An article in Transfusion and Aphersis Science https://t.co/xVFE09bsRo showed out of 72 Rh (D) negative patients 17% formed new Rh group antibodies after exposure to Rh (D) positive RBCs. #AABBpeptalk